Multiple myeloma
Conditions
Interventions
Experiment group:On the first day after transplantation, PEG-rhG-CSF was given 100 µg/kg subcutaneous injection once.
Sponsors
Affiliated Hospital of Jiangnan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Active MM in accordance with the criteria of the Chinese Guidelines for Diagnosis and Treatment of Multiple Myeloma (Revised 2022). Patients with multiple myeloma who were older than 18 years, had a physical fitness score of 2 or less, and received auto-HSCT between January 2024 and January 2027. The number of CD34 stem cells required for transplantation was 2×10^6 cells /kg.
Exclusion criteria
Exclusion criteria: Patients with other hematologic malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutrophil implantation time;6 months post-migration OS rate;hospitalization costs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Grade 3 /4 granulocyte deficiency duration;Incidence of infection;Platelet implantation time;Platelet transfusion volume;Incidence of grade IV anemia;Adverse reaction;PFS rate at 6 months after transplantation.; | — |
Countries
China
Contacts
Public ContactLiu tingting
Affiliated Hospital of Jiangnan University
Outcome results
None listed